aiming to do with the study that we have launched now.— aiming to do with the study that we have launched now. what about the develoin: have launched now. what about the developing world? _ have launched now. what about the developing world? as _ have launched now. what about the developing world? as he _ have launched now. what about the developing world? as he rightly - developing world? as he rightly pointed out, there are huge parts of the world that are currently seeing another wave of coronavirus infection, specifically omicron, but many in the developing world haven't even had their first shots. many in the developing world haven't even had theirfirst shots. is many in the developing world haven't even had their first shots. is the development of boosters coming at the expense of providing those first shots to people in the developing world? ., ., ~' ~' shots to people in the developing world? ~ :: ' ., world? look, i think 2021 was a difficult year — world? look, i think 2021 was a difficult year for _ world? look, i think 2021 was a difficult year for all _ world? look, i think 2021 was a difficult year for all of _ world? look, i think 2021 was a difficult year for all of the - difficult year for all of the vaccine producers and manufacturers. it was a difficult year to get supply under way and to get it out to countries that need it. i would say that in 2021, madera not provided about 25%, about 825 million palaces of the vaccine to low and middle income countries. we have committed to providing another billion doses this year. i think it's beginning to emerge and it's very interesting that the african union for example actually declined to take the option for the second